Clinton: SCOTUS Myriad Genetics Decision 'Terrific'

June 14 (Bloomberg) -- Former President Bill Clinton discusses the U.S. Supreme Court's decision in Association for Molecular Pathology v. Myriad Genetics, Inc. with Trish Reagan at the Clinton Global Initiative in Chicago. The ruling, which found human genes cannot be patented, will "generate untold thousands of jobs in this country," he says.
What To Watch: Greece, China Stocks, Oil
51:31 - Bloomberg's Jonathan Ferro briefs you on the day's top stories.
  • Paul Smith: Rent Costs Are Killing the High Street
  • Capital Controls: a Hard Pill to Swallow
  • China’s Decline Not a Bad Thing Long-Term: Sullivan